Sympathetic neurotransmission in spleens from aging Brown-Norway rats subjected to reduced sympathetic tone

J Neuroimmunol. 2018 Nov 15:324:1-15. doi: 10.1016/j.jneuroim.2018.08.010. Epub 2018 Aug 18.

Abstract

Senescence of innate and adaptive responses and low-grade inflammation (inflammaging) hallmarks normal aging, which increases vulnerability to infectious diseases, autoimmunity and cancer. In normal aging, sympathetic dysregulation contributes to the dysregulation of innate and adaptive immunity and inflammaging. Sympathetic innervation of immune cells in secondary immune organs regulates immune responses. Previously in Fischer 344 (F344) rats, we reported an age-related increase in sympathetic tone and sympathetic dysfunction in beta-adrenergic receptor (AR) signaling of splenic lymphocytes that contributes to immune senescence, although the responsible mechanisms remains unexplored. In this study, we extend our previous findings using the much longer-lived Brown-Norway (BN) rats, whose behavior and immune response profile differ strikingly from F344 rats. Here, we investigated whether increased sympathetic nerve activity (SNA) in the aging spleen contributes to age-related sympathetic neuropathy and altered neurotransmission in splenic lymphocytes in BN rats. Fifteen-month male BN rats received 0, 0.5 or 1.5 μg/kg/day rilmenidine intraperitoneally for 90 days to lower sympathetic tone. Untreated young and age-matched rats controlled for effects of age. We found that elevated SNA in the aging BN rat spleen does not contribute significantly to sympathetic neuropathy or the aging-induced impairment of canonical β-AR signal transduction. Despite the rilmenidine-induced increase in β-AR expression, splenocyte c-AMP production was comparable with age-matched controls, thus dampening nerve activity had no effect on receptor coupling to adenylate cyclase. Understanding how aging affects neuroimmune regulation in healthy aging rodent models may eventually lead to strategies that improve health in aging populations vulnerable to immunosenescence and low-grade systemic inflammation.

Keywords: Imidazoline-1 receptor agonist; Neurotransmission; Norepinephrine turnover; Sympathetic innervation; β-AR-stimulated cAMP production.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adrenergic beta-Agonists / metabolism
  • Adrenergic beta-Agonists / pharmacology
  • Aging / drug effects
  • Aging / metabolism*
  • Animals
  • Male
  • Norepinephrine / metabolism*
  • Organ Size / drug effects
  • Organ Size / physiology
  • Rats
  • Rats, Inbred BN
  • Receptors, Adrenergic, beta / metabolism*
  • Spleen / drug effects
  • Spleen / metabolism*
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / metabolism*
  • Sympatholytics / metabolism
  • Sympatholytics / pharmacology
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology

Substances

  • Adrenergic beta-Agonists
  • Receptors, Adrenergic, beta
  • Sympatholytics
  • Norepinephrine